Ablation of tumor progression locus 2 promotes a type 2 Th cell response in ovalbumin-immunized mice

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 105-113

  Watford, Wendy T ^a,e   Wang, Chun Chi ^b,f   Tsatsanis, Christos ^c,d   Mielke, Lisa A ^a,g   Eliopoulos, Aristides G ^d   Daskalakis, Constantine ^b   Charles, Nicolas ^a   Odom, Sandra ^a   Rivera, Juan ^a   O'Shea, John ^a   Tsichlis, Philip N ^c  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CRETE   (Greece)

^e UNIVERSITY OF GEORGIA   (United States)

^f REGENERON PHARMACEUTICALS INC   (United States)

^g WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; CYTOKINE; MAP3K8 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; ONCOPROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHOPNEUMONIA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHIL; EXUDATE; GENE LOCUS; IMMUNIZATION; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; MALE; MIXED CELL CULTURE; MOUSE; NONHUMAN; POLARIZATION; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TUMOR ABLATION; WILD TYPE; ANIMAL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PNEUMONIA; WESTERN BLOTTING;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN E; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; OVALBUMIN; PNEUMONIA; PROTO-ONCOGENE PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 73949143744     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803730     Document Type: Article

References (52)

1. Lee, G. R., S. T. Kim, C. G. Spilianakis, P. E. Fields, and R. A. Flavell. 2006. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24: 369-379.
2. Coffman, R. L. 2006. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat. Immunol. 7: 539-541.
3. Reiner, S. L. 2007. Development in motion: helper T cells at work. Cell 129: 33-36.
4. Stockinger, B., and M. Veldhoen. 2007. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19: 281-286.
5. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
6. Lewkowich, I. P., J. D. Rempel, and K. T. Hay Glass. 2004. Antigen-specific versus total immunoglobulin synthesis: total IgE and IgG1, but not IgG2a levels predict murine antigen-specific responses. Int. Arch. Allergy Immunol. 133: 145-153.
7. Lai, W. Q., H. H. Goh, Z. Bao, W. S. Wong, A. J. Melendez, and B. P. Leung. 2008. The role of sphingosine kinase in a murine model of allergic asthma. J. Immunol. 180: 4323-4329.
8. Brusselle, G., J. Kips, G. Joos, H. Bluethmann, and R. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12: 254-259.
9. Tomkinson, A., A. Kanehiro, N. Rabinovitch, A. Joetham, G. Cieslewicz, and E. W. Gelfand. 1999. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am. J. Respir. Crit. Care Med. 160: 1283-1291.
10. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
11. Suzuki, M., X. Zheng, X. Zhang, M. Li, C. Vladau, T. E. Ichim, H. Sun, L. R. Min, B. Garcia, and W. P. Min. 2008. Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J. Immunol. 180: 8461-8469.
12. Burrows, B., F. D. Martinez, M. Halonen, R. A. Barbee, and M. G. Cline. 1989. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 320: 271-277.
13. Sears, M. R., B. Burrows, E. M. Flannery, G. P. Herbison, C. J. Hewitt, and M. D. Holdaway. 1991. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325: 1067-1071.
14. Salvi, S. S., and K. S. Babu. 2000. Treatment of allergic asthma with monoclonal anti-IgE antibody. N. Engl. J. Med. 342: 1292-1293.
15. Strunk, R. C., and G. R. Bloomberg. 2006. Omalizumab for asthma. N. Engl. J. Med. 354: 2689-2695.
16. Coyle, A. J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183: 1303-1310.
17. Gould, H. J., B. J. Sutton, A. J. Beavil, R. L. Beavil, N. McCloskey, H. A. Coker, D. Fear, and L. Smurthwaite. 2003. The biology of IGE and the basis of allergic disease. Annu. Rev. Immunol. 21: 579-628.
18. Cruse, G., D. Kaur, W. Yang, S. M. Duffy, C. E. Brightling, and P. Bradding. 2005. Activation of human lung mast cells by monomeric immunoglobulin E. Eur. Respir. J. 25: 858-863.
19. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
20. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
21. Tanaka, H., M. Komai, K. Nagao, M. Ishizaki, D. Kajiwara, K. Takatsu, G. Delespesse, and H. Nagai. 2004. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am. J. Respir. Cell Mol. Biol. 31: 62-68.
22. Van Oosterhout, A. J., A. R. Ladenius, H. F. Savelkoul, I. Van Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147: 548-552.
23. Corrigan, C. J., A. Haczku, V. Gemou-Engesaeth, S. Doi, Y. Kikuchi, K. Takatsu, S. R. Durham, and A. B. Kay. 1993. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am. Rev. Respir. Dis. 147: 540-547.
24. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, et al. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87: 1541-1546.
25. Gonzalo, J. A., C. M. Lloyd, D. Wen, J. P. Albar, T. N. Wells, A. Proudfoot, C. Martinez-A, M. Dorf, T. Bjerke, and A. J. Coyle, et al. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188: 157-167.
26. Yang, M., S. P. Hogan, S. Mahalingam, S. M. Pope, N. Zimmermann, P. Fulkerson, L. A. Dent, I. G. Young, K. I. Matthaei, and M. E. Rothenberg, et al. 2003. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy Clin. Immunol. 112: 935-943.
27. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99: 1064-1071.
28. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185: 785-790.
29. Moore, P. E., T. L. Church, D. D. Chism, R. A. Panettieri, Jr., and S. A. Shore. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L847-L853.
30. Ceci, J. D., C. P. Patriotis, C. Tsatsanis, A. M. Makris, R. Kovatch, D. A. Swing, N. A. Jenkins, P. N. Tsichlis, and N. G. Copeland. 1997. Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11: 688-700.
31. Chiariello, M., M. J. Marinissen, and J. S. Gutkind. 2000. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the cjun promoter and to cellular transformation. Mol. Cell. Biol. 20: 1747-1758.
32. Patriotis, C., A. Makris, J. Chernoff, and P. N. Tsichlis. 1994. Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 91: 9755-9759.
33. Tsatsanis, C., C. Patriotis, S. E. Bear, and P. N. Tsichlis. 1998. The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc. Natl. Acad. Sci. U.S.A. 95: 3827-3832.
34. Tsatsanis, C., C. Patriotis, and P. N. Tsichlis. 1998. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB. Oncogene 17: 2609-2618. (Pubitemid 28544702)
35. Belich, M. P., A. Salmerón, L. H. Johnston, and S. C. Ley. 1999. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature 397: 363-368. (Pubitemid 129638157)
36. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, and G. Kollias, et al. 2000. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083.
37. Hatziapostolou, M., C. Polytarchou, D. Panutsopulos, L. Covic, and P. N. Tsichlis. 2008. Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration. Cancer Res. 68: 1851-1861.
38. Eliopoulos, A. G., C. D. Dumitru, C. C. Wang, J. Cho, and P. N. Tsichlis. 2002. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21: 4831-4840.
39. Das, S., J. Cho, I. Lambertz, M. A. Kelliher, A. G. Eliopoulos, K. Du, and P. N. Tsichlis. 2005. Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner. J. Biol. Chem. 280: 23748-23757.
40. Kaiser, F., D. Cook, S. Papoutsopoulou, R. Rajsbaum, X. Wu, H. T. Yang, S. Grant, P. Ricciardi-Castagnoli, P. N. Tsichlis, and S. C. Ley, et al. 2009. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206: 1863-1871.
41. Tsatsanis, C., K. Vaporidi, V. Zacharioudaki, A. Androulidaki, Y. Sykulev, A. N. Margioris, and P. N. Tsichlis. 2008. Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells. Proc. Natl. Acad. Sci. U.S.A. 105: 2987-2992.
42. Watford, W. T., B. D. Hissong, L. R. Durant, H. Yamane, L. M. Muul, Y. Kanno, C. M. Tato, H. L. Ramos, A. E. Berger, L. Mielke, et al. 2008. Tpl2 kinase regulates T cell interfereon-gamma production and host resistance to Toxoplasma gondii. J. Exp. Med. 205: 2803-2812.
43. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
44. Charles, N., W. T. Watford, H. L. Ramos, L. Hellman, H. C. Oettgen, G. Gomez, J. J. Ryan, J. J. O'Shea, and J. Rivera. 2009. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 30: 533-543.
45. Gri, G., S. Piconese, B. Frossi, V. Manfroi, S. Merluzzi, C. Tripodo, A. Viola, S. Odom, J. Rivera, M. P. Colombo, and C. E. Pucillo. 2008. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29: 771-781.
46. Strath, M., D. J. Warren, and C. J. Sanderson. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods 83: 209-215.
47. Eliopoulos, A. G., C. C. Wang, C. D. Dumitru, and P. N. Tsichlis. 2003. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22: 3855-3864.
48. Brusselle, G. G., J. C. Kips, J. H. Tavernier, J. G. van der Heyden, C. A. Cuvelier, R. A. Pauwels, and H. Bluethmann. 1994. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 24: 73-80.
49. Yamaoka, K., B. Min, Y. J. Zhou, W. E. Paul, and J. J. O'shea. 2005. Jak3 negatively regulates dendritic-cell cytokine production and survival. Blood 106: 3227-3233.
50. Sugimoto, K., M. Ohata, J. Miyoshi, H. Ishizaki, N. Tsuboi, A. Masuda, Y. Yoshikai, M. Takamoto, K. Sugane, S. Matsuo, et al. 2004. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J. Clin. Invest. 114: 857-866.
51. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106: 259-262.
52. Berg, S. F., S. Mjaaland, and S. Fossum. 1994. Comparing macrophages and dendritic leukocytes as antigen-presenting cells for humoral responses in vivo by antigen targeting. Eur. J. Immunol. 24: 1262-1268.